MAPS
Non-Profit & Charitable Organizations · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3141 Stevens Creek Blvd PMB 40563, San J...Phone Number
(831) 429-6362Website
www.maps.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
1
1
1
1
About MAPS
MAPS is a nonprofit organization dedicated to advancing research into psychedelics for psychological healing. They serve as a hub for psychedelic education, advocating for policy reform and harm reduction efforts while providing evidence-based resources to those interested in psychedelic therapies. Their intended clients include mental health professionals, individuals seeking alternative treatments, and advocates for drug policy reform. With a mission to end psychedelic prohibition, MAPS promotes the responsible use of psychedelics to unlock their therapeutic potential.Explore more
MAPS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MAPS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if MAPS has recently received funding, and reach out quickly before it becomes old news!
MAPS, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once MAPS has new funding data
Check out if MAPS is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on MAPS recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at MAPS
Product Launch: Get notified when MAPS launches new products
Click to see if MAPS had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at MAPS
Find more new buyers
Compare Similar Companies to MAPS
Compare insights from companies similar to MAPS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MAPS is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
MAPS is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about MAPS.
MAPS Tech Stack
A closer look at the technologies used by MAPS
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Person-Based
Richard Doblin, Executive Director, appeared on a podcast called "The Joe Rogan Experience" on 05/09/2025. Topics discussed include Psychedelic therapy, PTSD, MAPS.
Events, Podcast
Open Position
Open Position
Promotion
Executive Move
MAPS News & Media
University of Miami's Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
WASHINGTON, Aug. 25, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) has welcomed the announcement that the University of Miami has gifted the federal government its 1994 ibogaine Investigational New Drug (IND) application.MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA
WASHINGTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today responded to an August 9 report by Psychedelic Alpha indicating that Resilient Pharmaceuticals (formerly MAPS PBC and Lykos Therapeutics) has resubmitted its new drug application (NDA) for MDMA-assisted therapy for PTSD to the U.S. Food and Drug Administration (FDA). The resubmission follows the Complete Response Letter issued on August 9, 2024, which recommended additiMAPS Publishes Ibogaine Investigator's Brochure as a Free, Open-Access Resource
WASHINGTON, July 07, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) released an Ibogaine Investigator’s Brochure (IB), a comprehensive scientific and regulatory resource summarizing the current preclinical, safety, dosing, and observational data on ibogaine. It is the first time a technical document of this scope has been made freely and publicly available.Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the opening of speaker submission for Psychedelic Science 2027 (PS27), its flagship conference for psychedelic research, medicine, policy, and culture. Submission will remain open through 11:59 p.m. ET on Friday, September 18.
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding MAPS
Sign Up For FreeTo access detailed company insights
MAPS is a nonprofit organization dedicated to advancing research into psychedelics for psychological healing. They serve as a hub for psychedelic education, advocating for policy reform and harm reduction efforts while providing evidence-based resources to those interested in psychedelic therapies. Their intended clients include mental health profe... Read More
